文献速递认知障碍与痴呆

主观认知下降患者存在轻微神经心理缺陷并与脑脊液AD标志物相关

Minor neuropsychological deficits in patients with subjective cognitive decline.
PubMed 文献 · Neurology · 2020-07-07

该研究基于德国DELCODE队列的449名认知正常参与者(209名健康对照、240名主观认知下降患者),采用潜变量五认知域因子结构比较组间表现并分析其与脑脊液阿尔茨海默病标志物的关联。结果显示主观认知下降组在整体表现、记忆、执行功能和语言能力上较差,且这些域的表现与脑脊液β-淀粉样蛋白42/40及β-淀粉样蛋白42/磷酸化tau181相关。

要点

  • 主观认知下降患者在记忆、执行功能和语言能力上存在轻微缺陷。
  • 这些细微认知缺陷与脑脊液AD生物标志物相关,支持其作为临床前AD早期检测的潜在用途。
  • 在临床未受损阶段,主观认知下降已与客观认知表现下降相关。

核心结论

  • 在临床未受损的认知表现谱内,主观认知下降与记忆、执行功能和语言能力的轻微缺陷相关。
  • 这些细微认知缺陷与AD脑脊液生物标志物的关联支持其有效性和用于早期检测潜在临床前AD的用途。

研究设计与样本

  • 分析来自德国神经退行性疾病中心纵向认知障碍与痴呆研究(DELCODE)中期数据发布的449名认知正常参与者(209名健康对照、240名主观认知下降患者)。
  • 基线应用广泛神经心理学测试组合,建立包含学习与记忆、执行功能、语言能力、工作记忆和视空间功能的潜变量五认知域因子结构。

主要发现

  • 主观认知下降组相比健康对照在整体表现、记忆、执行功能和语言能力上表现更差(Cohen d ≈0.25-0.5,经年龄、性别调整的协方差分析)。
  • 这些认知域表现更差与较低脑脊液β-淀粉样蛋白42/40和脑脊液β-淀粉样蛋白42/磷酸化tau181呈中度相关(r ≈0.3),在全样本及主观认知下降亚组中均如此。

临床怎么用

  • 对主观认知下降患者可考虑进行记忆、执行功能和语言能力的细致神经心理评估。
  • 脑脊液AD生物标志物可能有助于识别主观认知下降中具有临床前AD病理的个体。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the nature and extent of minor neuropsychological deficits in patients with subjective cognitive decline (SCD) and their association with CSF biomarkers of Alzheimer disease (AD). METHOD: We analyzed data from n = 449 cognitively normal participants (n = 209 healthy controls, n = 240 patients with SCD) from an interim data release of the German Center for Neurodegenerative Diseases Longitudinal Cognitive Impairment and Dementia Study (DELCODE). An extensive neuropsychological test battery was applied at baseline for which we established a latent, 5 cognitive domain factor structure comprising learning and memory, executive functions, language abilities, working memory, and visuospatial functions. We compared groups in terms of global and domain-specific performance and correlated performance with different CSF markers of AD pathology. RESULTS: We observed worse performance (Cohen d = ≈0.25-0.5, adjusted for age, sex differences with analysis of covariance) in global performance, memory, executive functions, and language abilities for the SCD group compared to healthy controls. In addition, worse performance in these domains was moderately (r = ≈0.3) associated with lower CSF β-amyloid42/40 and CSF β-amyloid42/phosphorylated tau181 in the whole sample and specifically in the SCD subgroup. CONCLUSIONS: Within the spectrum of clinically unimpaired (i.e., before mild cognitive impairment) cognitive performance, SCD is associated with minor deficits in memory, executive function, and language abilities. The association of these subtle cognitive deficits with AD CSF biomarkers speaks to their validity and potential use for the early detection of underlying preclinical AD.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Wolfsgruber S, Kleineidam L, Guski J, et al. Minor neuropsychological deficits in patients with subjective cognitive decline. Neurology. 2020. PMID: 32636322. doi:10.1212/WNL.0000000000010142

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。